Philips Respironics BiPAP AVAPS noninvasive ventilator has been developed to help clinicians provide better, more efficient care for patients including children as young as seven years of age and who weigh more than 40 pounds. AVAPS (average volume assured pressure support) automatically adapts to disease progression and changing patient needs. Maintains optimal patient comfort without compromising patient care and efficacy, also simplifying the titration process. Patients who develop chronic hypoventilation may find BiPAP AVAPS a more comfortable and effective NIV therapy. For example, neuromuscular, COPD, and obesity hypoventilation patients are strong candidates for BiPAP AVAPS.